← All Mangoceuticals, INC filings

Mangoceuticals, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
MGRX
Mangoceuticals, INC
DEF: Mangoceuticals Seeks Stockholder Approval for Key Proposals Including Series B Amendment and Equity Incentive Plan
Mangoceuticals is convening a special meeting of stockholders to vote on proposals including amendments to the Series B Convertible Preferred Stock, adoption of the Second Amendment to the Equity Incentive Plan, and other corporate governance matters.
NASDAQ
MGRX
Mangoceuticals, INC
DEF 14A: Mangoceuticals, Inc. Sets Date for Annual Stockholders Meeting, Proposes Key Governance and Financial Approvals
Mangoceuticals, Inc. will hold its annual meeting on June 17, 2024, seeking stockholder approval for director elections, stock issuances, auditor ratification, and potential meeting adjournment.
NASDAQ
MGRX
Mangoceuticals, INC
DEF 14A: Mangoceuticals Seeks Stockholder Approval for Reverse Stock Split and Equity Incentive Plan Amendment
Mangoceuticals is asking stockholders to approve a reverse stock split to maintain its Nasdaq listing and an amendment to its equity incentive plan to attract and retain key personnel.